Dun & Bradstreet Holdings Inc. News
These Three Stocks Are Ready to Take Off, Credit Suisse Says
Health insurance and info tech companies are sitting at 'inflection points' with shares poised for gains of 25% to 100%, bank says.
IBM, CareDx: 5 Top Stock Gainers for Thursday
CareDx, IBM, Alphatec Holdings, Dun & Bradstreet and DTE Energy are some of the top stock gainers for Thursday.
Dun & Bradstreet Shares Climb in Wall Street Debut
Shares of business-information provider Dun & Bradstreet climb in their first day of trading.
Hold on for a Wild Ride: Cramer's 'Mad Money' Recap
From tax cuts to the Flynn fallout, Jim Cramer says investors have to be covered.
Stock Futures Up Despite North Korea Escalation, Charlottesville Violence
The president's claim Friday that the military is 'locked and loaded' didn't weigh on markets Sunday evening.
Market Recon: Another Fed Meeting Beckons
It's no secret that the Fed intends to remain on its current trajectory of tightening monetary policy.
Here Are 5 Stocks With Unusual Volume
Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst
Here's what 'Superinvestors' are doing during the latest surge in the stock market
Here's a technical look at how to trade a number of stocks rising with unusual volume flow.
Market recon: The direction of Oil has been somewhat shocking
Black gold hasn't moved how you would think.
Breaking News
Johnson & Johnson Stock Lower After Unveiling End To Global Baby Powder Sales In 2023
Johnson & Johnson, which began selling Baby Powder in 1894, will end all sales of the talc-based product next year.
Apple Stock Edges Higher After Report Indicates iPhone Demand Confidence
Apple is asking assemblers to put together 220 million iPhones this year, Bloomberg reported, a tally that largely matches 2021 levels.
Struggling Electric-Truck Maker Nikola Makes a Major Change
Electric-truck manufacturer Nikola, like the broad vehicle industry, has been struggling with supply-chain issues.
Illumina and the Quest for the (Holy?) Grail
DNA-sequencing leader Illumina swung to a loss in Q2 2022. Contributions from Grail didn't help.